Lyka Labs touches roof after Ipca Laboratories acquires around 26% stake in the company

26 Nov 2021 Evaluate

Lyka Labs is locked its upper circuit limit of Rs. 149.45, up by 7.10 points or 4.99% from its previous closing of Rs. 142.35 on the BSE.

The scrip opened at Rs. 149.45 and has touched a high and low of Rs. 149.45 and Rs. 149.45 respectively. So far 47016 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 142.35 on 25-Nov-2021 and a 52 week low of Rs. 19.05 on 22-Dec-2020.

Last one week high and low of the scrip stood at Rs. 142.35 and Rs. 118.10 respectively. The current market cap of the company is Rs. 428.77 crore.

The promoters holding in the company stood at 20.00%, while Institutions and Non-Institutions held 3.92% and 76.08% respectively.

Ipca Laboratories has acquired 26.574% of the paid-up share capital of Lyka Labs and has entered into a Joint Management Control Agreement with the Promoters of Lyka Labs. The cost of acquisition is Rs 97.89 crore. The Board of Directors of the Company at their meeting held on November 24, 2021 has approved the same. Consequent to this acquisition of shares, the Company has also made a public announcement to acquire 26% additional equity shares of the said company from its public shareholders under the SEBI (SAST) Regulations, 2011.


Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×